An FDA-approved non-surgical treatment option for Dupuytren’s Contracture

Available at the Center for Plastic Surgery, Xiaflex is an FDA-approved nonsurgical treatment option for individuals with Dupuytren’s contracture—the hand condition where the tissue in the palm of the hand thickens into nodules or cords. Dupuytren’s contracture develops slowly over time and can pull one or more fingers (commonly the ring and/or pinky finger) into a bent position that cannot be fully straightened, leading to difficulty with many daily tasks. Because it is a genetic condition commonly found in patients of Northern European descent, it is also referred to as “Viking disease.”

The treatment for Dupuytren’s contracture involves releasing or removing the cords within the hand to return finger motion. There are many ways to accomplish this including, surgical removal of the cord, needle aponeurotomy, or Xiaflex injections.

Xiaflex is an enzyme (collagenase) that when administered as an injection helps to break down the collagen that makes of the Dupuytren’s contracture cord. Following injection, the patient returns to the office after 1-5 days to have the finger straightened. Following straightening of the finger, patients temporarily wear a splint to help maintain the position of the finger and prevent recurrent contracture. Repeat injections could be necessary and can be done four weeks after the previous injection.

Dr. Adams has trained with leading users and educators of Xiaflex, allowing him to offer this safe and effective treatment to patients suffering from Dupuytren’s contracture in Fargo and in North Dakota.

If you would like to learn more about Xiaflex or Dupuytren’s contracture, contact Dr. Adams by clicking here or call (701) 412-2400 to schedule a consultation.